Mobile Health Technology for Personalized Tobacco Cessation Support in Laos
In Lao People's Democratic Republic (Lao PDR), 51% of adult men and 7% of adult women smoke tobacco. The development and evaluation of sustainable tobacco cessation interventions suitable for widespread adoption in nations such as Lao PDR are pressing public health needs. To address this need, the investigators propose
| Condition(s) | Cigarette Smoking |
|---|---|
| Status | Recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Summary | In Lao People's Democratic Republic (Lao PDR), 51% of adult men and 7% of adult women smoke tobacco. The development and evaluation of sustainable tobacco cessation interventions suitable for widespread adoption in nations such as Lao PDR are pressing public health needs. To address this need, the investigators propose a project that adapts a theoretically and empirically based mobile health (mHealth) technology to help people quit smoking cigarettes in Lao PDR. This mHealth approach includes a fully automated, interactive, personalized, smartphone-delivered intervention for behavioral treatment, delivered through our Insight™ platform. This proposed project for Lao PDR includes 2 main phases. In the R21 Phase, the investigators will use formative research methods to adapt our intervention |
| Who can participate | Inclusion Criteria: (pilot RCT in the R21 Phase and main RCT in the R33 Phase): 1. aged ≥18 years 2. self-reported current combustible cigarette smokers (smoked at least 100 cigarettes in lifetime and currently smoke ≥1 cigarette/day) 3. willing to set a quit date within 2 weeks of study enrollment 4. able to provide written informed consent to participate 5. able to read Lao (score ≥4 points on the Rapid Estimate of Adult Literacy in Medicine-Short Form). Exclusion Criteria: (pilot RCT in the R21 Phase and main RCT in the R33 Phase) 1. history of a medical condition that precludes use of NRT 2. ineligibility to participate based on medical or psychiatric conditions diagnosed by a physician/clinician 3. enrollment in another cessation program or current use of other cessation medications. |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Lead sponsor | University of Oklahoma |
| Locations | Champasak, Laos; Vientiane, Laos |
| Start date | 2022-04-27 |
| NCT ID | NCT05233228 |
| Official listing | https://clinicaltrials.gov/study/NCT05233228 |